Copenhagen, Denmark 21 April 2017 — Monsenso is a finalist for Best eHealth solutions in Europe. The Danish technology company developing mHealth solutions for mental health, was shortlisted for the Champions category. Of the 15 companies who applied in the same category, five of them were shortlisted to win the sought-after prize, which is organised by TICBioMed, with the objective to provide support for SMEs’ business success, offering a path to increase visibility and marketing opportunities to attract customers, partners and external capital.
Thomas Lethenborg, CEO at Monsenso, said, “This nomination for Best eHealth solutions in Europe is an extension of Monsenso’s growing success, driven by our commitment to establish Monsenso as an innovation leader in mHealth solutions for mental health.”
“Our efforts are underpinned by an excellent and dedicated team. The eHealth Competition is a coveted award among eHealth SMEs in Europe. The award recognises the innovation, social, demographic and economic impact of healthcare solutions, and we would like to congratulate all the finalists for their remarkable achievements,” added Mr. Lethenborg.
The finalists for the Competition of Best eHealth solutions in Europe will present their solution to the judging panel and over 700 delegates and speakers at Health 2.0, which showcases the latest innovations in healthcare, and is taking place from 3-5 May in Barcelona, Spain. The winner will be announced during the opening ceremony in Barcelona.
The Monsenso mHealth solution has been technically and clinically validated in clinical evaluation studies and randomised controlled trials (RCTs) and has a class 1 medical device CE Mark. Monsenso also holds an ISO 13485 certification, and is expected to obtain the ISO 27001 certification and become HIPAA compliant before the end of the year.
To read this press release in Danish click here.
For additional information contact:
Marketing and Communications Manager
+45 81 75 80 01